NovoCure Limited

NVCR

$15.84

Name : NovoCure Limited

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $1,844,502,144.00

EPSttm : -1.3

NovoCure Limited

$15.84

2.22%

$0.36

NVCR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

11.27

Margin Of Safety %

Put/Call OI Ratio

0.07

EPS Next Q Diff

-0.12

EPS Last/This Y

-0.03

EPS This/Next Y

0.43

Price

15.84

Target Price

27.14

Analyst Recom

1.86

Performance Q

2.66

Upside

-389.5%

Beta

0.98

Ticker: NVCR

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	NVCR	17.82	0.06	0.01	18005
2026-08-31	NVCR	17.66	0.06	1.29	18118
2026-09-02	NVCR	17.85	0.06	0.00	18126
2026-09-03	NVCR	17.64	0.06	0.04	18867
2026-09-04	NVCR	17.93	0.06	0.15	18887
2026-09-08	NVCR	16.82	0.06	0.05	18961
2026-09-09	NVCR	15.62	0.06	0.45	19059
2026-09-10	NVCR	15.35	0.07	0.95	19356
2026-09-11	NVCR	15.45	0.08	0.18	19741
2026-09-14	NVCR	16.23	0.08	1.30	19749
2026-09-15	NVCR	16.16	0.09	1.33	20072
2026-09-16	NVCR	16.22	0.08	0.00	20021
2026-09-17	NVCR	16.74	0.08	0.63	20032
2026-09-18	NVCR	16.68	0.08	0.05	20050
2026-09-21	NVCR	16.52	0.07	1.17	16218
2026-09-22	NVCR	16.66	0.07	0.00	16405
2026-09-23	NVCR	16.25	0.07	0.09	16800
2026-09-24	NVCR	16.19	0.07	0.00	17235
2026-09-25	NVCR	15.84	0.07	0.78	17468
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	NVCR	17.90	25.8	11.3	-1.25
2026-08-31	NVCR	17.66	25.8	11.8	-1.25
2026-09-01	NVCR	17.38	25.8	12.5	-1.25
2026-09-02	NVCR	17.82	25.8	17.8	-1.25
2026-09-03	NVCR	17.72	25.8	21.4	-1.25
2026-09-04	NVCR	17.93	25.8	18.7	-1.25
2026-09-08	NVCR	16.86	25.8	27.1	-1.25
2026-09-09	NVCR	15.64	25.8	28.5	-1.25
2026-09-10	NVCR	15.34	25.8	22.6	-1.25
2026-09-11	NVCR	15.50	25.8	19.4	-1.25
2026-09-14	NVCR	16.22	25.8	15.3	-1.25
2026-09-15	NVCR	16.17	25.8	21.0	-1.25
2026-09-16	NVCR	16.17	25.8	21.0	-1.25
2026-09-17	NVCR	16.73	25.8	17.0	-1.25
2026-09-18	NVCR	16.68	25.8	20.8	-1.25
2026-09-21	NVCR	16.52	25.8	21.7	-1.25
2026-09-22	NVCR	16.66	25.8	19.5	-1.25
2026-09-23	NVCR	16.25	25.8	23.3	-1.25
2026-09-24	NVCR	16.20	25.8	20.9	-1.25
2026-09-25	NVCR	15.84	25.8	22.9	-1.25
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	NVCR	-1.74	4.07	8.76
2026-08-31	NVCR	-1.74	5.13	8.76
2026-09-01	NVCR	-1.74	5.13	8.76
2026-09-02	NVCR	-1.74	5.13	8.76
2026-09-03	NVCR	-1.74	5.13	8.76
2026-09-04	NVCR	-1.64	5.13	8.76
2026-09-08	NVCR	-0.46	5.37	8.76
2026-09-09	NVCR	-0.46	5.37	8.76
2026-09-10	NVCR	-0.46	5.37	8.76
2026-09-11	NVCR	-0.46	5.37	10.31
2026-09-14	NVCR	-0.46	5.37	10.31
2026-09-15	NVCR	-0.46	5.37	10.31
2026-09-16	NVCR	-0.46	5.37	10.31
2026-09-17	NVCR	-0.46	5.37	10.31
2026-09-18	NVCR	-0.46	5.37	10.31
2026-09-21	NVCR	-0.46	5.37	10.31
2026-09-23	NVCR	-0.46	5.37	10.31
2026-09-24	NVCR	-0.46	5.37	10.31
2026-09-25	NVCR	-0.46	5.37	11.27
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.13

Avg. EPS Est. Current Quarter

-0.24

Avg. EPS Est. Next Quarter

-0.25

Insider Transactions

-0.46

Institutional Transactions

5.37

Beta

0.98

Average Sales Estimate Current Quarter

182

Average Sales Estimate Next Quarter

185

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

87.5

Max Drawdown 5-Year %

-92.1

Target Price

27.14

P/E

Forward P/E

PEG

P/S

2.64

P/B

5.46

P/Free Cash Flow

EPS

-1.31

Average EPS Est. Cur. Y

-1.25

EPS Next Y. (Est.)

-0.82

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-21.25

Relative Volume

0.71

Return on Equity vs Sector %

-70.2

Return on Equity vs Industry %

-55.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

22.9

◆ NVCR Healthcare

$15.84

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

23/25

Volume

9/15

Valuation

10/20

TP/AR

1/10

Options

7/10

RSI

41.9

Range 1M

21.4%

Sup Dist

0.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

19/30

Estimates

1/20

Inst/Vol

7/15

Options

7/10

EPS Yr

-2.5%

EPS NY

34.7%

52W%

51.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +71.3% upside

Quality

6/30

Valuation

14/30

Growth

14/25

Stability

7/10

LT Trend

1/5

Upside

+71.3%

Quality

NVCR — P/E HistoricalMedical Instruments & Supplies

NovoCure Limited

Sector: Healthcare

Industry: Medical Devices

Employees: 1605

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

NVCR

Latest News

—

Caricamento notizie per NVCR…

stock quote shares NVCR – NovoCure Limited Stock Price stock today

news today NVCR – NovoCure Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch NVCR – NovoCure Limited yahoo finance google finance

stock history NVCR – NovoCure Limited invest stock market

stock prices NVCR premarket after hours

ticker NVCR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVCR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y